MedAI Verdict
All comparisons

KATE vs Regard

Regard is sold partly to finance buyers. The vendor says it reviews 100% of the chart, recommends diagnoses with an evidence chain and drafts notes, and that no diagnostic logic reaches patients without physician approval. Its solutions include HCC Capture and a mid-revenue-cycle product for missed diagnoses before denials. Regard holds an ONC Health IT certification under the 2015 Cures Update, dated May 2024, shows Epic over FHIR R4 in its demo, and shows Banner Health, WakeMed and Kettering Health among its customers. The vendor's Sentara case study reports 17% more CC/MCC capture and 4x ROI per user.

Mednition's customer is the ED nursing director, and the vendor's 2019 study claimed 26.9% higher triage accuracy, with the paper then in peer review. Regard works on diagnoses and revenue capture across a hospital and KATE on acuity at the ED door, so the two do different jobs.

Decision support · Reviewed November 2, 2026

KATE logo

KATE

by Mednition · founded 2014

KATE AI recommends emergency department triage acuity and flags sepsis risk from EHR data at triage.

Regard logo

Regard

by Regard

AI platform that reviews the full EHR chart, suggests supported diagnoses with evidence, and drafts clinical notes for physician approval.

When to pick each one

KATE

  • Vendor-run 2019 study claims 26.9% better triage accuracy
  • Triage acuity and sepsis risk for the ED
Read the full KATE review

Regard

  • ONC Health IT certification, 2015 Cures Update, May 2024
  • Epic over FHIR R4 shown in demo
  • HCC capture and denial prevention modules
Read the full Regard review

Score

Each row shows points earned of points available under the published rubric.

KATE

12of 100

Tracked

Regard

9of 100

Tracked
Score by dimension for KATE and Regard
DimensionKATERegardDifference
FDA clearance0 / 120 / 120
HIPAA / SOC2 / BAA0 / 100 / 100
EHR integrations (count)0 / 5.61.7 / 5.6-1.7
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 4.81.9 / 4.8-1.9
Bidirectional write-back0 / 1.20 / 1.20
Peer-reviewed papers0 / 210 / 210
RCT / meta-analysis / systematic review0 / 90 / 90
Funding & adoption signal3 / 123 / 120
Pricing transparency1.3 / 2.51.3 / 2.50
Years in market6 / 60 / 6+6

Scroll horizontally to see every column.

How scores are computed

Pricing

KATE

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price.

Regard

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price.

Evidence

KATE

FDA decisions

No FDA decision cited in our research as of November 2, 2026.

Regard

FDA decisions

No FDA decision cited in our research as of November 2, 2026.

Compliance and integrations

Documented from each vendor’s own pages.

SpecKATERegard
Free tierNo / unverifiedNo / unverified
HIPAANo / unverifiedNo / unverified
SOC 2 Type IINo / unverifiedNo / unverified
EHR integrationsNot specifiedEpic
Founded2014n/a
HQUSn/a

Scroll horizontally to see both columns.

Common questions

Open the full decision support comparison

Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.